GUEST CONTRIBUTORS

  • CROs Can Be Indispensable As Pharma Companies Focus On Value
    CROs Can Be Indispensable As Pharma Companies Focus On Value

    The healthcare industry’s transition to value-based care is putting a lot of pressure on pharmaceutical companies in terms of margins and the need to demonstrate improved outcomes at lower costs. In attempting to create breakthrough therapies and “beyond the pill” solutions with fewer resources, companies are demonstrating an increased appetite for outsourcing functions – and Contract Research Organizations (CROs) could be the beneficiaries.

  • Israel’s Emergence As A Go-To Market For Conducting Clinical Trials
    Israel’s Emergence As A Go-To Market For Conducting Clinical Trials

    Driven by the steep costs of hosting clinical trials in the United States and Western Europe, pharmaceutical companies have increasingly turned to global markets to conduct trials over the last decade. During that timeframe, Israel has emerged as an attractive market – bolstered by its high-quality medical infrastructure and well-trained physician workforce, diverse patient population and widespread adherence to Good Clinical Practice (GCP) standards.

  • Phase I Clinical Supply Landscape: Trends, Demarcation And Security
    Phase I Clinical Supply Landscape: Trends, Demarcation And Security

    The core addressable early phase market is USD 11.9 billion growing with a CAGR of 2 – 3 percent. Early-phase trials are outsourced at greater than 60 percent by pharma, as the trials are costly and small in number. The supply market for early phase is comprised by CROs, research centers, and academic institutes. The market size that is comprised by the CROs is estimated to be around USD 8 billion, which is about 67 percent of the early phase market.

  • Pharma And Physicians – The Key To Successful Clinical Trials

    Traditionally in the pharmaceutical and biotech industry worlds, a pharma company develops a candidate product and then works with a group of doctors to test that product under careful standards and procedures—very much managed by the pharma company. If the product shows therapeutic value and safety, it becomes available to prescribers to administer to patients.

  • Are You Recruiting Nurses For Your Clinical Research?

    In clinical trials involving patients with complex medical diseases such as chronic kidney disease or cancer, nursing skills are especially useful. Nurses are trained on how to interact with, evaluate and appropriately care for, patients. They are familiar with complex medical regimes and are comfortable talking with and educating patients.

More From Guest Contributors

CLINICAL TRIAL WHITE PAPERS

More Clinical Trial White Papers

ABOUT CLINICAL LEADER

Welcome to Clinical Leader, the premier online community that helps streamline clinical research by connecting trial sponsors and cutting edge service providers. Clinical Leader is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market. Connect, Collaborate, Contribute.

Visitors are enriched with valuable information on CRO, Pre-Clinical Contract Research Organization, Bio-Analytical Contract Research Organization, Clinical Contract Research Organization, Pharmacovigilance, Clinical Data Management, Electronic Patient Reported Outcomes (ePRO), Point-of-Care Testing (POCT), Patient Recruitment, Electronic Data Capture (EDC), Clinical Trials Management Systems (CTMS) and more that can improve your business and make it more profitable.

Please take a moment to join our community and discover the benefits of your free membership.

INDUSTRY INSIGHTS

  • Advancing Safety and Efficacy Studies with Novel Surgical Applications
    Advancing Safety and Efficacy Studies with Novel Surgical Applications

    Novel therapeutics such as gene and cell therapies, nanoparticles, and combination products requiring targeted delivery,  novel treatments for wound healing, cardiovascular disease, and bone regeneration,  and new medical device technologies call for innovative surgical procedures in preclinical trials to determine safety and efficacy.

  • Virtual Clinical Trials: The Future of Patient Engagement?
    Virtual Clinical Trials: The Future of Patient Engagement?

    The clinical trial process plays an essential role in drug discovery by effectively demonstrating the efficacy and safety of a pharmaceutical compound. Unfortunately, current estimates show that only about 1 in 10 drugs that actually start the clinical trials process are eventually granted FDA approval.

  • TransCelerate Companies Lead The Way In Adopting Risk-Based Monitoring
    TransCelerate Companies Lead The Way In Adopting Risk-Based Monitoring

    I recently had the opportunity to attend DIA. While listening to the panelists, I realized TransCelerate companies appear to be the furthest along in their journey of risk-based monitoring (RBM), and even so, RBM is still relatively new for most of them. For the companies presenting at DIA, the main reasons given for implementing RBM were to comply with the impending ICH E6(R2) guidelines, increase the overall quality of their data, provide better oversight of patient safety and target their efforts on the areas of trials that matter most.

  • Medrio’s eClinical Data Management Quick Facts
    Medrio’s eClinical Data Management Quick Facts

    As eClinical data management continues its march toward becoming the norm in clinical research, the landscape becomes increasingly populated with companies offering EDC. It can be difficult for EDC providers to stand out among broadening competition. Here at Medrio, we’ve grown with the times and created a model that has kept us unique as the industry develops. Here’s a quick look at the ways we’ve remained a leader in EDC for clinical research.

  • Integrated Workflows: The Unsexy Plumbing Of Clinical Trials
    Integrated Workflows: The Unsexy Plumbing Of Clinical Trials

    There is no doubt that clinical research is critical to the advancement of medicine and public health. But conducting such research is a complex, resource intensive endeavor that relies on a multitude of stakeholders, workflows, processes, and information systems.

More Industry Insights

LIFE SCIENCE INDUSTRY EVENTS

Reacting to “Human Error” – Moving Beyond “Retraining” As A Response September 27, 2016
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
The HireLifeScience.com Career Fair 2016 September 27, 2016
Edison, NJ
Introduction to Biostatistics: Collecting and Summarizing Data September 28, 2016
1pm-3pm EDT, Online Training
Price:  $349 - Introductory Rate
New Pharma Compliant Google Ad Formats – Implementation Tips For Success September 29, 2016
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
More Industry Events

TRAINING COURSES

Reacting to “Human Error” – Moving Beyond “Retraining” As A Response September 27, 2016
1pm-2:30pm EDT, Online Training
Introduction to Biostatistics: Collecting and Summarizing Data September 28, 2016
1pm-3pm EDT, Online Training
New Pharma Compliant Google Ad Formats – Implementation Tips For Success September 29, 2016
1pm-2:30pm EDT, Online Training
Pediatric Clinical Trials: Special Considerations and Requirements October 6, 2016
1pm-2:30pm EDT, Online Training
Biosimilars: Preparing For Opportunities And Challenges October 11, 2016
1pm-2:30pm EDT, Online Training
More Upcoming Courses